Search details
1.
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Cancer Immunol Immunother
; 73(7): 116, 2024 May 07.
Article
in English
| MEDLINE | ID: mdl-38713408
2.
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.
Invest New Drugs
; 41(2): 284-295, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36867316
3.
Uveal melanoma: laboratory advances and new frontiers in patient care.
Curr Opin Ophthalmol
; 32(3): 301-308, 2021 May 01.
Article
in English
| MEDLINE | ID: mdl-33606406
4.
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies.
J Oncol Pharm Pract
; 27(3): 555-559, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-32423325
5.
Correlation of novel ALKATI with ALK immunohistochemistry and clinical outcomes in metastatic melanoma.
Histopathology
; 77(4): 601-610, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32564377
6.
Characterization of uveal melanoma clinical trial design: a systematic review to establish an elusive standard of care.
Acta Oncol
; 59(11): 1401-1408, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32609032
7.
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma.
Acta Oncol
; 59(4): 434-437, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-31920132
8.
Adjuvant therapy for resected high-risk melanoma.
Semin Cutan Med Surg
; 37(2): 109-111, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-30040087
9.
c-Met expression and MET amplification in malignant pleural mesothelioma.
Ann Diagn Pathol
; 23: 1-7, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-27402216
10.
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.
Nat Med
; 2024 Jun 13.
Article
in English
| MEDLINE | ID: mdl-38871975
11.
Regulation of pancreatic cancer growth by superoxide.
Mol Carcinog
; 52(7): 555-67, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-22392697
12.
Use of Talimogene Laherparepvec to Treat Cutaneous Squamous Cell Carcinoma in a Renal Transplant Patient.
Case Rep Dermatol
; 15(1): 99-104, 2023.
Article
in English
| MEDLINE | ID: mdl-37383323
13.
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
NPJ Precis Oncol
; 7(1): 120, 2023 Nov 14.
Article
in English
| MEDLINE | ID: mdl-37964004
14.
BRAF Immunohistochemical Studies of Pediatric Conjunctival Lesions.
Cornea
; 2022 Dec 13.
Article
in English
| MEDLINE | ID: mdl-36729648
15.
The Mechanisms of Action of Tumor Treating Fields.
Cancer Res
; 82(20): 3650-3658, 2022 10 17.
Article
in English
| MEDLINE | ID: mdl-35839284
16.
Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma.
Pancreas
; 50(6): 796-802, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-34347727
17.
Mechanisms of Resistance to PD-1 Checkpoint Blockade.
Drugs
; 80(5): 459-465, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32096021
18.
Biomarkers in Precision Cancer Immunotherapy: Promise and Challenges.
Am Soc Clin Oncol Educ Book
; 40: e275-e291, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32453632
19.
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
Cancer Cell
; 38(1): 60-78.e12, 2020 07 13.
Article
in English
| MEDLINE | ID: mdl-32473656
20.
Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab.
Cancer Med
; 8(18): 7637-7643, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31677253